Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes

Zhang,Suojun; Xie,Ruifan; Zhao,Tianyuan; Yang,Xiong; Han,lin; Ye,Fei; Lei,Ting; Wan,Feng

doi:10.3892/ijo.2014.2629

Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes

Authors:
- Suojun Zhang
- Ruifan Xie
- Tianyuan Zhao
- Xiong Yang
- lin Han
- Fei Ye
- Ting Lei
- Feng Wan
View Affiliations

Affiliations: Department of Neurosurgery and Chinese-German Lab of Molecular Neurooncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China
Published online on: August 29, 2014 https://doi.org/10.3892/ijo.2014.2629
Pages: 1989-1996

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioma stem cells (GSCs), characterized by self-renewal, multi-potentiality and tumorigenicity, are responsible for the tumor propagation, recurrence and resistance to traditional treatments, representing a critical therapeutic target. Neural stem cells (NSCs) possess inherent tropism to brain tumor cells and inhibit their growth. However, there is a limited understanding of the mechanism underlying NSC tropism and the effect of NSC migration on GSC stemness phenotypes. In the present study, we showed that GSCs exhibited enhanced chemotaxis for NSC tropism compared with their differentiated cells. Chemokines secreted by GSCs contributed to the targeted migration of NSCs. Hypoxia enhanced NSC tropism via the upregulated chemokine expression of GSCs, such as VEGF, EGF and bFGF. In vitro migration of NSCs induced GSC differentiation and reduced stem-like phenotypes. Moreover, in vivo data provided direct evidence that transplanted NSCs could migrate to GSCs from either the homolateral or contralateral brain injection site, which prolonged the survival of grafted mice. Taken together, these findings show that NSCs preferentially migrate to GSCs and reduce their stemness phenotypes, raising the intriguing possibility that the targeted migration of NSCs can be applied as a novel therapeutic strategy to target these intractable brain tumors.

View Figures

View References

1	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
2	Fuller GN and Scheithauer BW: The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 17:304–307. 2007. View Article : Google Scholar : PubMed/NCBI
3	Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004. View Article : Google Scholar : PubMed/NCBI
4	Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821–5828. 2003.PubMed/NCBI
5	Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
6	Sakariassen PO, Immervoll H and Chekenya M: Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia. 9:882–892. 2007. View Article : Google Scholar : PubMed/NCBI
7	Eyler CE and Rich JN: Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar
8	Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006. View Article : Google Scholar
9	Liu Q, Nguyen DH, Dong Q, et al: Molecular properties of CD133⁺ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol. 94:1–19. 2009.
10	Spencer DD, Robbins RJ, Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med. 327:1541–1548. 1992.
11	Freed CR, Breeze RE, Rosenberg NL, et al: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N Engl J Med. 327:1549–1555. 1992.PubMed/NCBI
12	Imitola J, Raddassi K, Park KI, et al: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA. 101:18117–18122. 2004. View Article : Google Scholar : PubMed/NCBI
13	Armstrong RJ and Svendsen CN: Neural stem cells: from cell biology to cell replacement. Cell Transplant. 9:139–152. 2000.PubMed/NCBI
14	Carbajal KS, Schaumburg C, Strieter R, Kane J and Lane TE: Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA. 107:11068–11073. 2010. View Article : Google Scholar : PubMed/NCBI
15	Aboody KS, Brown A, Rainov NG, et al: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
16	Benedetti S, Pirola B, Pollo B, et al: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 6:447–450. 2000. View Article : Google Scholar : PubMed/NCBI
17	Herrlinger U, Woiciechowski C, Sena-Esteves M, et al: Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther. 1:347–357. 2000. View Article : Google Scholar : PubMed/NCBI
18	Staflin K, Honeth G, Kalliomaki S, Kjellman C, Edvardsen K and Lindvall M: Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res. 64:5347–5354. 2004. View Article : Google Scholar : PubMed/NCBI
19	Glass R, Synowitz M, Kronenberg G, et al: Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci. 25:2637–2646. 2005. View Article : Google Scholar : PubMed/NCBI
20	Yip S, Sabetrasekh R, Sidman RL and Snyder EY: Neural stem cells as novel cancer therapeutic vehicles. Eur J Cancer. 42:1298–1308. 2006. View Article : Google Scholar : PubMed/NCBI
21	Kim SU: Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev. 7:130–140. 2011. View Article : Google Scholar : PubMed/NCBI
22	Spencer D: Fighting brain tumors while protecting the brain: the stem cell story. Neurology. 76:e69–e70. 2011. View Article : Google Scholar : PubMed/NCBI
23	Yu JJ, Sun X, Yuan X, Lee JW, Snyder EY and Yu JS: Immunomodulatory neural stem cells for brain tumour therapy. Expert Opin Biol Ther. 6:1255–1262. 2006. View Article : Google Scholar : PubMed/NCBI
24	Ahmed AU, Alexiades NG and Lesniak MS: The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr Opin Mol Ther. 12:546–552. 2010.PubMed/NCBI
25	Aboody KS, Najbauer J and Danks MK: Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15:739–752. 2008. View Article : Google Scholar : PubMed/NCBI
26	Zhang SJ, Ye F, Xie RF, et al: Comparative study on the stem cell phenotypes of C6 cells under different culture conditions. Chin Med J. 124:3118–3126. 2011.PubMed/NCBI
27	Campos B, Wan F, Farhadi M, et al: Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 16:2715–2728. 2010. View Article : Google Scholar : PubMed/NCBI
28	Laks DR, Masterman-Smith M, Visnyei K, et al: Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells. 27:980–987. 2009. View Article : Google Scholar : PubMed/NCBI
29	Zhang S, Luo X, Wan F and Lei T: The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates. Neurochem Res. 37:2659–2666. 2012. View Article : Google Scholar : PubMed/NCBI
30	Busletta C, Novo E, Valfre DBL, et al: Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. Stem Cells. 29:952–963. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kendall SE, Najbauer J, Johnston HF, et al: Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells. 26:1575–1586. 2008. View Article : Google Scholar : PubMed/NCBI
32	Schmidt NO, Przylecki W, Yang W, et al: Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia. 7:623–629. 2005. View Article : Google Scholar
33	Mercapide J, Rappa G, Anzanello F, King J, Fodstad O and Lorico A: Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Int J Cancer. 126:1206–1215. 2010.
34	Pollard SM, Conti L, Sun Y, Goffredo D and Smith A: Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex. 16(Suppl 1): i112–i120. 2006. View Article : Google Scholar : PubMed/NCBI
35	Sun Y, Pollard S, Conti L, et al: Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci. 38:245–258. 2008. View Article : Google Scholar : PubMed/NCBI
36	Pollard SM, Yoshikawa K, Clarke ID, et al: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar : PubMed/NCBI
37	Xu Q, Wang S, Jiang X, et al: Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol. 34:624–631. 2007. View Article : Google Scholar
38	Zhao D, Najbauer J, Garcia E, et al: Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res. 6:1819–1829. 2008. View Article : Google Scholar : PubMed/NCBI
39	Pistollato F, Abbadi S, Rampazzo E, et al: Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells. 28:851–862. 2010.PubMed/NCBI
40	Chirasani SR, Sternjak A, Wend P, et al: Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain. 133:1961–1972. 2010. View Article : Google Scholar : PubMed/NCBI
41	Kim SK, Kim SU, Park IH, et al: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res. 12:5550–5556. 2006. View Article : Google Scholar
42	van Eekelen M, Sasportas LS, Kasmieh R, et al: Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene. 29:3185–3195. 2010.PubMed/NCBI
43	Ehtesham M, Kabos P, Gutierrez MA, et al: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 62:7170–7174. 2002.